Skip to content

Transctunaous Pulsed Radiofrequency Therapy in Carpal Tunnel Syndrome

Efficacy of Transctunaous Pulsed Radiofrequency Therapy in Carpal Tunnel Syndrome

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05500079
Enrollment
60
Registered
2022-08-12
Start date
2021-08-01
Completion date
2023-06-01
Last updated
2023-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Neuropathy, Chronic Pain

Keywords

carpal tunnel syndrome, pulsed radiofrequency treatment, transcutaneous pulsed radiofrequency

Brief summary

The aim of this study is to examine the effect of transcutaneous pulsed radiofrequency current in the treatment of carpal tunnel syndrome.

Detailed description

Carpal tunnel syndrome (CTS) is the most common peripheral neuropathy. Wrist splint is the first-line treatment option for CTS. Pulsed radiofrequency therapy is used in the treatment of chronic pain. 60 carpal tunnel syndrome patients diagnosed with electroneuromyelography will be included in the study. 30 patients will wear wrist splints for 1 month. In the other 30 patients, pulsed radiofrequency current will be given through the wrist median nerve trace. RF current will be applied through transcutaneous pads. It will be applied once a week for a total of 2 sessions, 8 minutes each. Boston carpal tunnel syndrome questionnaire with visual analog scale (VAS) will be applied to all patients before and after the treatment at 1 week and 1 month. Our aim is to compare the effectiveness of wrist splint and pulsed rf therapy.

Interventions

A wrist splint is a It stabilizes your wrist. Wearing a wrist splint minimizes pressure on the median nerve.

OTHERPulsed radiofrequency current

Pulsed rf current is delivered to the median nerve trace via transcutaneous pads. Pain expression is suppressed in the dorsal horn of the spinal cord.

Sponsors

Diskapi Teaching and Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Carpal tunnel syndrome detected by electroneuromyography * Positive Tinel sign

Exclusion criteria

* Thenar muscle atrophy * Weakness in the abductor pollicis brevis muscle

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline in Pain on the Visual Analog Scale (VAS) at Week 2 and 4Baseline, Week 2 and 4The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between 0=no pain and 10=worst pain.
Boston Carpal Tunnel Syndrome Questionnaire before treatmentBefore treatmentThe Boston Carpal Tunnel Questionnaire (BCTQ) is a disease-specific measure of self-reported symptom severity and functional status. It is frequently used in the reporting of outcomes from trials into interventions for carpal tunnel syndrome. ıncluding Symptom Severity Scale is 11: no symptoms, 55: worst symptoms and Functional Disability Scale (FDS) no difficulties:8, worst difficulties: 40

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026